Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSAReal-world evidence of PYLARIFY’s effectiveness in ...
Medical Dialogues10d
Urine-based test detects aggressive prostate cancer: Study
Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...
Knowridge Science Report11d
A new urine test could detect prostate cancer more accurately
The new urine test looks at 18 genes that are linked to high-risk prostate cancer. Previous research showed that MPS2 could ...
Targeted Oncology11d
ARANOTE Features Significant rPFS Benefit of Darolutamide/ADT in mHSPC
In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...
News-Medical.Net12d
New urine test shows promise for prostate cancer screening
The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...
Dear Doctor: Man’s prostate tumors are considered small. Shouldn’t he have them removed?
Prostate cancer kills 35,000 men a year, according to Dr. Roach. But not all cancers are treated the same way.
Your Good Health: Prostate cancer patient gets put under surveillance
Some men in your situation will choose surgery, radiation or medication to lower testosterone. Some experts recommend ...
Opinion
Sun Journal13dOpinion
Prostate cancer patient gets put under active surveillance
I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One blood test showed a PSA level of 13 ng/mL, and a second was 17 ng/mL. So, I ...